Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Adi Mondshine"'
Autor:
Renata Ferrarotto, Vasudha Mishra, Elad Herz, Adar Yaacov, Oz Solomon, Rami Rauch, Adi Mondshine, Maria Motin, Tal Leibovich-Rivkin, Matti Davis, Joel Kaye, Christopher R. Weber, Le Shen, Alexander T. Pearson, Ari J. Rosenberg, Xiangying Chen, Alka Singh, Jon C. Aster, Nishant Agrawal, Evgeny Izumchenko
Publikováno v:
Cell Death and Disease, Vol 13, Iss 8, Pp 1-11 (2022)
Abstract Adenoid cystic carcinoma (ACC) is an aggressive salivary gland malignancy with limited treatment options for recurrent or metastatic disease. Due to chemotherapy resistance and lack of targeted therapeutic approaches, current treatment optio
Externí odkaz:
https://doaj.org/article/56e0238430084912a4c2eb44ee06b45b
Autor:
Matti Davis, Udi Gluschnaider, Rami Rauch, Bill Kramer, Adi Mondshine, Genia Alpert, Oz Solomon, Jon C. Aster, Andrea Vergara-Silva, Evgeny Izumchenko, Renata Ferrarotto, John V. Heymach
Publikováno v:
Cancer Research. 79:4885-4885
Goal: To evaluate Notch inhibitor monotherapy and combination (combo) therapy in Adenoid Cystic Carcinoma (ACC) Patient Derived Xenograft (PDX) models with and without activating Notch mutations (mt). ACC is a rare salivary gland malignancy with no s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af751f8953531a69a8656d59f85e3b20
https://doi.org/10.1158/1538-7445.am2019-4885
https://doi.org/10.1158/1538-7445.am2019-4885
Autor:
Matti Davis, Ido Sloma, Jon C. Aster, Rami Rauch, Esther Channah Broner, Evgeny Izumchenko, Adi Mondshine, Udi Gluschnaider, Oz Solomon, Genia Alpert
Publikováno v:
Journal of Clinical Oncology. 37:1064-1064
1064 Background: The Notch pathway is activated during mammary gland development and has been implicated as a key driver in breast cancer. There is an urgent need to identify new therapeutic strategies for triple-negative breast cancer (TNBC), a sub-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a39a89bf59dacbf30a92a3401dcf49a0
https://doi.org/10.1200/jco.2019.37.15_suppl.1064
https://doi.org/10.1200/jco.2019.37.15_suppl.1064
Autor:
Adi Mondshine, David Altreuter, Arlyssa Birt, Nir Gefen, Genia Alpert, Sunil Anamandla, Jeno Gyuris, Lorena Lerner, Nadia Gurvich, Hong Wang, Guy Cinamon, Keren Cohen Merimi, Orli Even Or
Publikováno v:
Cancer Research. 77:1601-1601
Cancer immunotherapies are revolutionizing cancer treatment. Unfortunately, a large proportion of patients with solid tumors do not respond to currently available immune-therapeutics. The lack of response is due to a variety of mechanisms tumors adop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6894220475d17b12e662ec3d4ad15246
https://doi.org/10.1158/1538-7445.am2017-1601
https://doi.org/10.1158/1538-7445.am2017-1601